ScholarLens Back to search
2014•International Journal of Pharma and Bio SciencesRequires access

CURRENT TRENDS IN SIMVASTATIN THERAPY FOR ENHANCED EFFICIENCY

S. Aarthy, B.N. Vedha Hari, D. Ramya Devi

Open publisher page 1 citations

Abstract

Statins are mainly used as the inhibitors of enzyme 3-hydroxy-3 methyl glutaryl coenzyme A (HMG COA) reductase which is responsible for the synthesis of cholesterol. Apart from the cholesterol reducing activity they also facilitate as anti- inflammatory and cardio-protective agents. Solubility is one of the main parameter for any drug to achieve the expected therapeutic effects. Since Simvastatin is poorly soluble drug with less half life of about 2 hours, various types of formulations are being currently prepared to enhance its solubility which in turn may improve the bioavailability of the drug. Studies reveal that different methodologies were carried out to overcome the bioavailability issue which is the key limiting factor. The present study focuses on the different types of novel formulation approaches of Simvastatin, currently available for enhancing the bioavailability and efficacy of the drug in the biological system.

About this research paper

What this paper is about

Statins are mainly used as the inhibitors of enzyme 3-hydroxy-3 methyl glutaryl coenzyme A (HMG COA) reductase which is responsible for the synthesis of cholesterol. Apart from the cholesterol reducing activity they also facilitate as anti- inflammatory and cardio-protective agents. Solubility is one of the main parameter for any drug to achieve the expected therapeutic effects. Since Simvastatin is poorly soluble drug with less half life of about 2 hours, various types of formulations are being currently prepared to enhance its solubility which in turn may improve the bioavailability of the drug. Studies reveal that different methodologies were carried out to overcome the bioavailability issue which is the key limiting factor. The present study focuses on the different types of novel formulation approaches of Simvastatin, currently available for enhancing the bioavailability and efficacy of the drug in the biological system.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Statins are mainly used as the inhibitors of enzyme 3-hydroxy-3 methyl glutaryl coenzyme A (HMG COA) reductase which is responsible for the synthesis of cholesterol. Apart from the cholesterol reducing activity they also facilitate as anti- inflammatory and cardio-protective agents. Solubility is one of the main parameter for any drug to achieve the expected therapeutic effects. Since Simvastatin is poorly soluble drug with less half life of about 2 hours, various types of formulations are being currently prepared to enhance its solubility which in turn may improve the bioavailability of the drug. Studies reveal that different methodologies were carried out to overcome the bioavailability issue which is the key limiting factor. The present study focuses on the different types of novel formulation approaches of Simvastatin, currently available for enhancing the bioavailability and efficacy of the drug in the biological system.

Key concepts: Simvastatin, Bioavailability, Drug, Pharmacology, Limiting, Chemistry, International Journal of Pharma and Bio Sciences, Reductase

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
CURRENT TRENDS IN SIMVASTATIN THERAPY FOR ENHANCED EFFICIENCY — Research Paper | ScholarLens